Vitekta (elvitegravir) - Ulwazi lweNtsholongwane kaGawulayo

Iziyobisi zivimbela i-HIV ukuba igxothise i-Cell Genetic Machinery

Ukwahlula

I-Vitekta (elvitegravir) yicirrheviral ekhethwe njenge- integrase inhibitor esetyenziselwa unyango lwe- HIV . I-Integrase inhibitors isebenza ngokuthintela i-enzyme ye-HIV ebizwa ngokuba yi-integrase, leyo i-HIV isebenzisayo ukudibanisa i-coding yayo kwi-DNA yeselula. Ngokuthintela integrase, intsholongwane ayikwazi ukugqiba umjikelo wayo wobomi kwaye idale ezinye ii-virions ze-HIV.

I-Vitekta yavunywa yi-US Food and Drug Administration (FDA) ngoSeptemba 2014 ukuze isebenzise abantu abadala ngaphambili babonelele unyango lwe-HIV.

I-Elvitegravir iyinxalenye yesigxina esilungisiweyo somnxeba iStribild (esaziwayo ngokubizwa ngokuba yi "Quad Pill") kunye nesibini sesizukulwana sesiStribild esibizwa ngokuthi nguGenvoya .

UkuPhathwa kweziMilo

I-Vitekta ifumaneka kwiifomathi ezimbini zeethebhulethi:

Isistim

I-Vitekta kufuneka isetyenziswe rhoqo kwiinkqubo zonyango kunye ne- HIV protease inhibitor (PI) kunye ne- Norvir (ritonavir) , i- agent "yokwandisa" eyenza ukuxilongwa kwezilwanyana ezihamba kunye negazi. I-Vitekta kufuneka ithathwe ngokutya.

Imilinganiselo ephakanyisiweyo iyahluka ngokukhetha izidakamizwa ngale ndlela:

IVitekta Umthamo weProtease Inhibitor Umlinganiselo we-Norvir (ritonavir)
85mg rhoqo ngosuku Reyataz (atazanavir) 300mg kanye ngosuku 100mg rhoqo ngosuku
85mg rhoqo ngosuku Kaletra (400mg lopinavir + 100 mg ritonavir) kabini imihla ngemihla Akukho mfuneko yokuba i-ritonavir sele iqulethwe kwi-Kaletra
150mg rhoqo ngosuku I-Prezista (darunavir) 600mg kabini imihla ngemihla 100mg kabini imihla ngemihla
150mg rhoqo ngosuku Lexiva (fosamprenavir) 700mg kabini imihla ngemihla 100mg kabini imihla ngemihla
150mg rhoqo ngosuku Aptivus (tipranavir) 500mg kabini imihla ngemihla 200mg kabini imihla ngemihla

Iziphumo eziPhakathi

KwisiGaba III sesifundo sezonyango zomntu, ininzi yeziphumo zecala yeziyobisi ziye zafunyanwa kwizigulane ezithatha iVitekta. Iziganeko eziqhelekileyo, ezichazwe ubuncinane kwi-2% yabathathi-nxaxheba zibandakanya:

Iziphumo eziqhelekileyo ezichaphazelekayo ziquka intlungu yesisu, ukunyanzelisa, ukukhawuleza, ukukhathala nokuhlanza. Iziphumo eziqhelekileyo zivame ukuhamba ixesha elide, kwaye izigulana ezimbalwa ziyeka ngenxa yokunyamezela unyango.

Ukuchasana kweziyobisi

I-Vitekta akufanele ithatyathwe ngamachiza alandelayo okanye izongezelelo zemfuyo:

Njalo uxelele ugqirha wakho nasiphi na isilwanyana okanye isongezelelo, esimiselweyo okanye esingasimiselweyo, ukuba ungathatha ngaphambi kokuba uqalise nayiphi na unyango lwe-antiretroviral.

Ulwalamano lwe-Antiretroviral Drug

Ukusetyenziswa kweVitekta kunye nezidakamizwa ezilandelayo ze-antiretroviral kunokubangela ukuba kukho ukulahlekelwa yempembelelo yokwelapha yesilwanyana esilandelayo okanye ukwanda kweempembelelo:

Ezinye izinto

I-Antacids inokuthintela i-Vitekta ukuba ilandelwe kakuhle. Ukuba usebenzisa i-counter-counteracacid (umzekelo, i-Rolaids, i-Tums, i-Milk ye-Magnesia), kucetyiswa ukuba kuthathe iiyure ezimbini ngaphambi okanye emva kweDoloji yeVotaz.

Abafazi mabacebise ugqirha ukuba ngaba bathatha okanye baceba ukuthatha iipilisi zokulawula ukuzalwa. I-Vitekta, xa isetyenziswe ngeNorvir, inokunciphisa kakhulu ingxube ye-plasma ye- ethinyl estradiol / i- hormonal contraceptive.

Ezinye iindlela zokucetywa kwe-hormonal contraception zinconywa. Ungalokothi ukwandise ama-dosage ye-hormonal contraceptive. Kucetyiswa ukuba unina onomnyobisi angalusanga ukuba unesifo sengculaza njengoko kunokusasazela intsholongwane.

I-Vitekta iqukethe i-lactose ngoko qi niseka ukuba ucebise ugqirha wakho ukuba unayo i-lactose engavumiyo.

Imithombo:

US Administration and Drug Administration (FDA). "I- VITEKTA - UKUZIPHILA KWENGCACISO NGEZIBONELELO ." I-Silver Srpring, e-Maryland; fi kelele ngoFebruwari 3, 2015.

FDA. "I-FDA iyavuma ipilisi entsha yentsebenziswano ye-HIV kwezinye izigulane." Silver Spring, eMaryn; ukukhutshwa kwenkcazelo ekhutshwe ngomhla ka-Agasti 27, 2012.

KwiSayensi zeGiliyadi. " IGenvoya - eziPhambili zeNgcaciso yoLwazi." Foster City, California; fi kelelwa ngoDisemba 14, 2015.